Sales chief drives roll-out of gene editing in aquaculture
Genetics services supplier, the Centre for Aquaculture Technologies (CAT), has made a senior appointment to lead the company’s expanding global rollout of innovation in genetic improvement, particularly in commercial-scale genome editing for aquaculture.
CAT said that Matt Kramer, who joins the San Diego-based company as the senior vice president of global sales and marketing, is a seasoned commercial leader with more than two decades of experience driving commercial growth in genomics and various life sciences sectors.
His expertise is anchored in a strong foundation in genomics, molecular diagnostics, and next generation sequencing technologies.
Real-world impact
Kramer said his new role gives him the opportunity to help shape how genomic and genome-editing technologies transition from research tools into real-world impact.
“Genome editing offers transformative benefits for the global aquaculture industry by enabling targeted genetic improvements that enhance operational productivity, resilience, and sustainability, as complementary methods to traditional selective breeding strategies,” added Kramer.
“My passion has always been to work for companies that drive innovation, and CAT provides exactly that opportunity.”
A new era
CAT chief executive John Buchanan said Kramer’s experience and leadership will be instrumental as the company expands the commercialisation of genome editing in aquaculture globally.
“I look forward to introducing him to our clients and am confident that, together with the rest of our team, we will lead CAT into an exciting new era – further driving innovation, boosting productivity and sustainability, and supporting our core mission of feeding people responsibly,” added Buchanan.
